dalteparin
Showing 1 - 25 of 32
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Nephrotic Syndrome, Thromboembolic Disease Trial in Aarhus (Dalteparin, Apixaban)
Recruiting
- Nephrotic Syndrome
- Thromboembolic Disease
- Dalteparin
- Apixaban
-
Aarhus, DenmarkAarhus University Hospital
May 20, 2022
Bone Sarcoma, Femur Fracture, Lymphoma Trial in Houston (Dalteparin)
Completed
- Bone Sarcoma
- +6 more
- Dalteparin
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2020
Kidney Failure Trial in London (Dalteparin)
Completed
- Kidney Failure
- Dalteparin
-
London, Ontario, CanadaLondon Health Sciences Centre
Feb 20, 2020
Cancer-associated Thrombosis, Esophageal Cancer, Stomach Cancer Trial in Seoul (Rivaroxaban, Dalteparin, apixaban)
Unknown status
- Cancer-associated Thrombosis
- +9 more
- Rivaroxaban
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 2, 2020
Cerebral Vein Thrombosis, Deep Vein Thrombosis, Gonadal Thrombosis Trial in United States (Apixaban, Dalteparin, Questionnaire
Completed
- Cerebral Vein Thrombosis
- +11 more
- Apixaban
- +2 more
-
Scottsdale, Arizona
- +17 more
Jul 31, 2020
Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) Trial in Worldwide (Edoxaban, Dalteparin, Low
Completed
- Venous Thromboembolism (VTE)
- +3 more
- Edoxaban
- +2 more
-
Brandon, Florida
- +8 more
Feb 8, 2019
Stroke Trial in Canada, India (Dalteparin, Placebo)
Unknown status
- Stroke
- Dalteparin
- Placebo
-
Halifax, Nova Scotia, Canada
- +7 more
Feb 18, 2020
Venous Thromboprophylaxis in Bariatric Surgery
Completed
- Obesity
- Dalteparin
- (no location specified)
Oct 17, 2018
Superficial Thrombophlebitis Trial in Ljubljana (Dalteparin)
Completed
- Superficial Thrombophlebitis
- Dalteparin
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
May 1, 2018
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Los Angeles (dalteparin, lenalidomide,
Terminated
- Stage I Multiple Myeloma
- +2 more
- dalteparin
- +3 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Nov 27, 2017
Venous Thromboembolism Trial in Worldwide (Apixaban, Dalteparin)
Unknown status
- Venous Thromboembolism
- Apixaban
- Dalteparin
-
Los Angeles, California
- +126 more
Nov 13, 2019
Embolism and Thrombosis Trial in Canada (Dalteparin, Warfarin)
Completed
- Embolism and Thrombosis
- Dalteparin
- Warfarin
-
Halifax, Nova Scotia, Canada
- +5 more
Aug 25, 2017
Injectable Anticoagulants for Thromboprophylaxis Post
Completed
- Thrombosis, Venous
- dalteparin
- +3 more
- (no location specified)
May 15, 2017
Pancreatic Cancer, Venous Thromboembolism Trial in Houston (Dalteparin)
Completed
- Pancreatic Cancer
- Venous Thromboembolism
- Dalteparin
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 20, 2016
Breast Cancer, Colorectal Cancer, Lung Cancer Trial in Canada, United States (dalteparin, standard therapy)
Completed
- Breast Cancer
- +4 more
- dalteparin
- standard therapy
-
Scottsdale, Arizona
- +19 more
Jul 12, 2016
Arterial Thromboembolic Events, Atrial Fibrillation Trial in Durham (Placebo, Dalteparin)
Completed
- Arterial Thromboembolic Events
- Atrial Fibrillation
- Placebo
- Dalteparin
-
Durham, North CarolinaDuke Clinical Research Institute
Feb 8, 2016
Pancreatic Cancer, Thromboembolism Trial in United States (dalteparin, gemcitabine HCl, quality-of-life assessment)
Terminated
- Pancreatic Cancer
- Thromboembolism
- dalteparin
- +2 more
-
Mobile, Alabama
- +12 more
Oct 13, 2015
Sickle Cell Disease, Vaso-occlusive Crisis Trial in Durham (Placebo, Dalteparin)
Completed
- Sickle Cell Disease
- Vaso-occlusive Crisis
- Placebo
- Dalteparin
-
Durham, North CarolinaDuke University
Jan 30, 2015
Septic Shock Trial in Canada (Unfractionated heparin, Dalteparin)
Completed
- Septic Shock
- Unfractionated heparin
- Dalteparin
-
Winnipeg, Manitoba, Canada
- +8 more
Jul 9, 2014
Pancreatic Cancer, Thromboembolism Trial in United Kingdom (dalteparin, gemcitabine HCl, diagnostic laboratory biomarker
Completed
- Pancreatic Cancer
- Thromboembolism
- dalteparin
- +2 more
-
Hull, England, United Kingdom
- +7 more
Aug 9, 2013
Coagulation, Blood, Compression Devices, Intermittent Pneumatic, Postoperative Complications Trial in Parma (device, drug,
Terminated
- Coagulation, Blood
- +3 more
- Sequential compression device therapy
- +2 more
-
Parma, PR, ItalyUniversity Hospital / Azienda Ospedaliero-Universitaria
Nov 4, 2013